Led by its German Corporate Practicegroup Head Lutz Angerer, Hogan Lovells has advised the listed Danish company Ambu A/S on the acquisition of invendo medical GmbH by way of a share deal. The purchase price of EUR 225 million includes contingent milestone and earn-out payments of up to EUR 110 million.

Invendo Medical is a leading developer of sterile, single-use HD endoscopy products in the field of gastroenterology and gastrointestinal surgery. Started in 2002, invendo medical is a medical devices company that employs 35 people and is located in Kissing, Germany. Invendo has developed the world’s first single-use gastrointestinal platform of which the second version of the first product – a HD colonoscope – is expected to be CE marked and have FDA clearance in 2018. 

Today, Ambu operates in the field of pulmonary endoscopy (visualisation of the airways) of which there are approximately 5 million procedures annually. With the acquisition of invendo medical, Ambu enters the field of gastrointestinal endoscopy (visualisation of the stomach and intestines) of which there are approximately 70 million procedures annually.

Lutz Angerer commented: "As a global full-service law firm with a very strong life sciences industry expertise we are the perfect law firm for transactions like this. This transaction featured one of the longest and most complicated purchase agreements my team has ever worked on, mainly because, among other things, of the combination of milestone and earn-out payments."

Hogan Lovells for Ambu:

Munich

Dr. Lutz Angerer (Partner, Lead), Andreas Thun (Counsel, Co-Lead), Dr. Nikolas Zirngibl (Partner), Thomas Weber (Counsel), Dr. Thomas Richter (Associate), Dr. Benjamin Fekonja (Associate, all Corporate/M&A);

Dr. Falk Loose (Counsel, Tax);

Sabrina Handke (Senior Associate, Real Estate);

Dr. Martin Pflüger (Counsel, IP Law).

Hamburg

Christian Stoll (Partner, IP Law).

Frankfurt

Dr. Kerstin Neighbour (Partner), Sarah Islinger (Associate, both Employment).